SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-004073
Filing Date
2022-02-11
Accepted
2022-02-11 17:13:01
Documents
14
Period of Report
2022-02-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41556
2 ex99-1.htm EX-99.1 8066
3 ex99-2.htm EX-99.2 71457
  Complete submission text file 0001493152-22-004073.txt   305511

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rspi-20220208.xsd EX-101.SCH 3036
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rspi-20220208_lab.xml EX-101.LAB 34476
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rspi-20220208_pre.xml EX-101.PRE 22597
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3294
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16467 | Film No.: 22622652
SIC: 2834 Pharmaceutical Preparations